Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Kyorin patent covers new NK1 antagonists for urinary incontinence and other uses

Sep. 8, 2003

Second approvable letter issued for duloxetine

Sep. 4, 2003

Bayer researchers describe two novel series of Rho kinase inhibitors

Sep. 3, 2003

Levitra receives FDA approval

Aug. 25, 2003

Preliminary results of North American Cystistat trial for interstitial cystitis

Aug. 22, 2003

Improved safety profile for transdermal oxybutynin vs. oral tolterodine in overactive bladder

Aug. 19, 2003

Yamanouchi and GlaxoSmithKline to copromote Vesicare in U.S.

Aug. 13, 2003

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Aug. 12, 2003

Levitra is effective in men of diverse ethnic origin

Aug. 11, 2003

Collaborative Study Group to conduct KRX-101 phase II/III program

Aug. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...